Effectiveness and Implementation of a Mindfulness Intervention for Depressive Symptoms Among Adults in a FQHC

Not Applicable

Completed

• Conditions: Stress, Physiological; Stress, Psychological; Depressive Symptoms
• Interventions: Behavioral: mindfulness

• Registration Number: NCT03620721
• Lead Sponsor: Northwestern University

Brief Summary

The objective of this project is to examine the clinical effectiveness of a mindfulness intervention on reducing depressive symptoms among socio-economically disadvantaged, racial/ethnic minority adults and explore factors related to implementation in a Federally Qualified Health Center (FQHC). This research will be used to develop a generalizable model for delivery of streamlined mental health interventions in community based settings that will be broadly disseminated and scalable to other populations. Black and Hispanic adults are more likely than those who are White to receive depression treatment in primary care, where antidepressants are the most commonly offered treatment. However, Black and Hispanic adults are less likely than Whites to find antidepressants acceptable. A mindfulness depression intervention provided within primary care may be more accessible and acceptable for low-income, racial/ethnic minority individuals, a severely underserved population. The investigators will conduct a randomized controlled trial to test the clinical effectiveness of a mindfulness intervention (M-Body) on reducing depressive symptoms, compared to usual care, among low-income racial/ethnic minority adults in a FQHC. The M-Body intervention is based on Mindfulness Based Stress Reduction and has been tailored for the FQHC setting and patient population. Adults (N=254) with depressive symptoms will be recruited from a FQHC in the Chicago, IL area that serves majority racial/ethnic minority individuals (90%) living at or below the poverty line (74%). Half of the patients will be randomized to the M-Body intervention arm where they will receive 8-weeks of mindfulness training led by FQHC staff and the other half will be randomized to usual care. Information on factors relevant to implementation of the intervention in the FQHC will be obtained by convening a series of workgroups and individual interviews with FQHC staff, executive leadership and community stakeholders. Specific Aims: 1) Determine the effectiveness of M-Body on reducing depressive symptoms compared to enhanced usual care for racial/ethnic minority adults in a FQHC; 2) Explore potential mediators (stress related biomarkers, mindfulness) and moderators (age, personal, social, environmental stressors) of the intervention's effect; 3) Conduct a broad assessment of organizational and individual agency factors related to preparation and implementation of the M-Body intervention in a FQHC using a mixed methods approach.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2018-07-23
• Study First Submitted QC: 2018-08-02
• Study First Posted: 2018-08-08
• Study Start: 2019-03-01
• Primary Completion: 2023-07-31
• Study Completion: 2023-08-30
• Status Verified: 2023-12
• Last Update Submitted: 2023-12-04
• Last Update Posted: 2023-12-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 245

Inclusion Criteria

• 18-65 years old
• mild to severe depressive symptoms (Patient Health Questionnaire-9, PHQ-9, total score ≥ 5)
• English speaking

Read More

Exclusion Criteria

• PHQ-9 total score <5
• past 30-day suicidal ideation
• current, regular practice of meditation (≥ 4 per week)

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
M-Body	mindfulness	mindfulness group intervention

Primary Outcome Measures

Name	Time	Method
Depressive Symptoms	6 months	Inventory of Depressive Symptoms (IDS-C), 30 items rated on a 0-3 point scale, total scores range from 0-84

Secondary Outcome Measures

Name	Time	Method
Anxiety	6 months	Generalized Anxiety Disorder (GAD-7), 7 items, rated on a 0-3 point scale
Anger	6 months	Anger Self-Report Questionnaire (ASRQ), 30 items rated on a 1-6 point scale

Trial Locations

Locations (1)

Northwestern University Asher Center for the Study and Treatment of Depressive Disorders; 🇺🇸 Chicago, Illinois, United States